Publication: Gut and oral microbiota profiling in patients (pts) with hormone receptor-positive (HR plus ) metastatic breast cancer (MBC) receiving pembrolizumab (P) plus eribulin (E): CALADRIO
No Thumbnail Available
Identifiers
Date
2022-05-05
Authors
Teng, N.
Dalby, M. J.
Kiu, R.
Robinson, T.
Cortes, M. Gion
Bermejo De las Heras, B.
Perez Garcia, J. M.
Calvo-Martinez, L.
Prat, A.
Marquez Vazquez, R.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
